Short-term and long-term success of electrical cardioversion in atrial fibrillation in managed care system

International Archives of Medicine

Volumn 2, Issue 1, 2009, Pages

  Kuppahally, Suman S ^a   Foster, Elyse ^b   Shoor, Stanford ^c   Steimle, Anthony E ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; FLECAINIDE; IBUTILIDE; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; RECURRENT DISEASE; TREATMENT OUTCOME;

EID: 77953413868     PISSN: None     EISSN: 17557682     Source Type: Journal    
DOI: 10.1186/1755-7682-2-39     Document Type: Article

References (33)

1. Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. IC Van Gelder HJ Crijns WH Van Gilst, Am J Cardiol 1991 68 1 41 6 10.1016/0002-9149(91)90707-R 2058558
2. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. IC Van Gelder HJ Crijns RG Tieleman, Arch Intern Med 1996 156 22 2585 92 10.1001/archinte.156.22.2585 8951302
3. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion. A meta-analysis of randomized control trials. SE Coplen EM Antman JA Berlin, Circulation 1990 82 4 1106 16 2144796
4. Management of atrial fibrillation. EL Pritchett, N Engl J Med 1992 326 19 1264 71 1560803
5. Recurrence of paroxysmal atrial fibrillation or flutter after successful cardioversion in patients with normal left ventricular function. MJ Suttorp JH Kingma EM Koomen, Am J Cardiol 1993 71 8 710 3 10.1016/0002-9149(93)91015-A 8447270
6. Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation. GE Kochiadakis NE Igoumenidis ME Hamilos PG Tzerakis NC Klapsinos GI Chlouverakis, et al. Am J Cardiol 2004 94 12 1563 6 10.1016/j.amjcard.2004.08.041 15589019
7. Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. H Oral JJ Souza GF Michaud, N Engl J Med 1999 340 24 1849 54 10.1056/NEJM199906173402401 10369847
8. Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence-a lesson from the HOT CAFE Polish Study. DA Kosior G Opolski B Wozakowska-Kaplon D Rabczenko, Cardiology 2005 104 1 35 44 10.1159/000086053 15942183
9. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). V Fuster LE Ryden DS Cannom HJ Crijns AB Curtis KA Ellenbogen, et al. J Am Coll Cardiol 2006 48 4 854 906 10.1016/j.jacc.2006.07. 009 16904574 (Pubitemid 44175743)
10. Does advanced age affect the immediate and long-term results of direct-current external cardioversion of atrial fibrillation? S Fumagalli L Boncinelli E Bondi, J Am Geriatr Soc 2002 50 7 1192 7 10.1046/j.1532-5415.2002. 50304.x 12133012
11. Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation. M Frick V Frykman M Jensen-Urstad J Ostergren M Rosenqvist, Clinical cardiology 2001 24 3 238 44 10.1002/clc.4960240313 11288971
12. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. G Boriani I Diemberger M Biffi G Domenichini C Martignani C Valzania, et al. International journal of clinical practice 2007 61 5 748 56 10.1111/j.1742-1241.2007.01298.x 17493088
13. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. AT Gosselink HJ Crijns IC Van Gelder, Jama 1992 267 24 3289 93 10.1001/jama.267.24.3289 1597910
14. Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide. DGb Zarembski PE Nolan Jr MK Slack, Arch Intern Med 1995 155 17 1885 91 10.1001/archinte.155.17.1885 7677555
15. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. D Roy M Talajic P Dorian, N Engl J Med 2000 342 13 913 20 10.1056/NEJM200003303421302 10738049
16. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. D Roy M Talajic P Dorian S Connolly MJ Eisenberg M Green, et al. N Engl J Med 2000 342 13 913 20 10.1056/ NEJM200003303421302 10738049
17. Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke? Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. B Olshansky EN Heller LB Mitchell, J Am Coll Cardiol 2005 45 12 2026 33 10.1016/j.jacc.2005.03. 020 15963405
18. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. L Djousse D Levy EJ Benjamin, Am J Cardiol 2004 93 6 710 3 10.1016/j.amjcard.2003.12.004 15019874
19. Cardioversion of atrial fibrillation in the elderly. ALKK-Study Group. Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausaerzte. J Carlsson U Tebbe J Rox, Am J Cardiol 1996 78 12 1380 4 10.1016/S0002-9149(96)00647-9 8970410
20. Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: atrial dimension versus volume. AS Volgman JS Soble A Neumann, Am J Card Imaging 1996 10 4 261 5 9012394
21. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. HC Dittrich JS Erickson T Schneiderman, Am J Cardiol 1989 63 3 193 7 10.1016/0002-9149(89)90284-1 2909999
22. Atrial and ventricular volume and function evaluated by magnetic resonance imaging in patients with persistent atrial fibrillation before and after cardioversion. SK Therkelsen BA Groenning JH Svendsen GB Jensen, Am J Cardiol 2006 97 8 1213 9 10.1016/j.amjcard.2005.11.040 16616028
23. A comparison of rate control and rhythm control in patients with atrial fibrillation. DG Wyse AL Waldo JP DiMarco, N EnglJ Med 2002 347 23 1825 33
24. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. IC Van Gelder VE Hagens HA Bosker, N Engl J Med 2002 347 23 1834 40 10.1056/NEJMoa021375 12466507
25. Atrial fibrillation and cognitive disorders in older people. T Sabatini GB Frisoni P Barbisoni, J Am Geriatr Soc 2000 48 4 387 90 10798464
26. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. CA Morillo GJ Klein DL Jones, Circulation 1995 91 5 1588 95 7867201
27. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. J Ausma M Wijffels F Thone, Circulation 1997 96 9 3157 63 9386188
28. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. A Boldt U Wetzel J Lauschke, Heart 2004 90 4 400 5 10.1136/hrt.2003.015347 15020515
29. A clinical study of patients with and without recurrence of paroxysmal atrial fibrillation after pulmonary vein isolation. J Chen PI Hoff KS Erga, Pacing Clin Electrophysiol 2005 28 Suppl 1 86 9 10.1111/j.1540-8159.2005.00021.x 15683535
30. Rate Control vs. Pulmonary Vein Isolation. MD Gonzalez, Am J Geriatr Cardiol 2005 14 1 26 30 10.1111/j.1076-7460.2005.03340.x 15654150
31. Radiofrequency ablation in the pulmonary veins for paroxysmal, drug-resistant atrial fibrillation. EJ Thompson DA Reich JL Meadows, Dimens Crit Care Nurs 2004 23 6 255 63 10.1097/00003465-200411000-00005 15586038
32. Surgical treatment of atrial fibrillation; a systematic review. K Khargi BA Hutten B Lemke, Eur J Cardiothorac Surg 2005 27 2 258 65 10.1016/j.ejcts. 2004.11.003 15691679
33. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. CW Israel G Gronefeld JR Ehrlich, J Am Coll Cardiol 2004 43 1 47 52 10.1016/j.jacc.2003. 08.027 14715182